Comorbid children to be vaccinated for COVID-19 first: Govt official
The Union government will prioritise children with comorbidities during the COVID-19 vaccination drive for children in the country, National Immunization Technical Advisory Group (NTAGI) Chairperson Dr NK Arora said on Sunday.
"We'll prioritise COVID-19 vaccination for children with comorbidities so that we immediately immunise them and rest of the children who are healthy can be immunised subsequently," ANI quoted Dr Arora as saying.
The Drugs Controller General of India (DCGI) had in August approved Zydus Cadila's DNA vaccine for emergency use in adults and children aged 12 years and above. Now, the vaccines are waiting to be introduced in the national vaccination programme.
In the month of June, the WHO-AIIMS in a joint survey found out that seroprevalence was 55.7 per cent in the age group below 18 years and 63.5 per cent in 18 years and above.
ZyCoV-D is a needle-free vaccine manufactured by Ahmedabad-based Zydus Cadila. Till date, this is the only vaccine that has received Emergency Use Authorisation (EUA) for administering in children between 12 to 18 years of age group.
Govt to identify high-risk kids
While talking about the government's plan to vaccinate children between 12 to 18 years of age in the country, the NTAGI chief said that they are trying to identify those who are at the highest risk of getting the severe disease and the need for hospitalisation.
"Within the next couple of weeks, the list will be available in the public domain. In addition, we are also making arrangements at different parts of the country so that these children do not have to travel and within their district, the vaccine is made available," Dr Arora said.